Acceleron Pharma Inc.
Methods of identifying ActRIIB variants
Last updated:
Abstract:
In certain aspects, the present invention provides compositions and methods for increasing red blood cell and/or hemoglobin levels in vertebrates, including rodents and primates, and particularly in humans.
Status:
Grant
Type:
Utility
Filling date:
27 Oct 2016
Issue date:
13 Aug 2019